THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES;LABORATOIRE HRA-PHARMA
发明人:
申请号：
IL20718210
公开号：
IL207182A
申请日:
2010.07.25
申请国别(地区):
IL
年份:
2015
代理人:
摘要：
The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17±-acetoxy-11²-[4- N , N -dimethylamino-phenyl)-19-norpregna- 4, 9-diene-3, 20-dione (ulipristal acetate) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.
